Nurse-led Smoking Cessation With Further Follow-up in Lifestyle Centres - a Randomized Pilot Study
Smoking Cessation After a Cardiovascular Disease Event With Hospital-based Nurse-coordination and Further Follow-up Care in Lifestyle Centres With Free Cessation Aids - an Interdisciplinary Randomized Pilot Study
1 other identifier
interventional
58
1 country
1
Brief Summary
The purpose of this randomized controlled pilot study is to test whether an in-hospital nurse-led smoking cessation intervention increases the refferal rate to healty life-centers in the municipalities. We will also describe the proportion who succeed in quitting smoking between the intervention group and the control group and obtain new knowledge about the patient and system factors of importance for participation to healty life-centers and for successful and unsuccessful smoking cessation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 7, 2021
CompletedStudy Start
First participant enrolled
February 25, 2021
CompletedFirst Posted
Study publicly available on registry
February 26, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2022
CompletedOctober 18, 2022
October 1, 2022
1.3 years
January 7, 2021
October 17, 2022
Conditions
Outcome Measures
Primary Outcomes (2)
Differences in participation rate at healthy life-centers between the intervention group and the control group measured by telephone interview with personnell at the healthy life-centers
Differences in participation rate at healthy life-centers between the intervention group and the control group measured by telephone interview with personnell at the healthy life-centers
8-12 weeks after randomization
Differences in use of smoking cessation aids between the intervention group and the control group
Differences in use of smoking cessation aids between the intervention group and the control group measued by patient self-report and collected from the prescription mediator in the hospital record
8-12 weeks after randomization
Secondary Outcomes (2)
Difference in point prevalence of smoke-free (no cigarettes last 7 days) after 6 months
12 weeks after randomization
Difference between the groups in proportion who quit smoking between the groups
12 weeks after randomization
Study Arms (2)
Intervention group
EXPERIMENTALControl group
NO INTERVENTIONInterventions
information, motivational interview, refferal to healty life-centers, free cessation aids
Eligibility Criteria
You may qualify if:
- Age\> 18 years and smokes at least 1 cigarette daily
- Hospitalized with a cardiovascular event (i.e. myocardial infarction, heart failure, unstable or stable angina, achyarrhythmias, bradyarrhythmias, carotid stenosis or claudication with need for peripheral revascularization)
- Sign informed consent and is expected to participate according to ICH / GCP
You may not qualify if:
- Does not meet the criteria to participate in the pilot project, i.e. patients who do not usually live or work in the Vestre Viken catchment area
- Chronic renal failure stage 4 or known allergic reaction to varenicline
- Any condition (e.g. psychosis, alcohol abuse, dementia) or situation that may pose a significant risk to the participant, confuse the results or make participation unethical
- Lack of Norwegian and English knowledge
- Short life expectancy (\<12 months)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Vestre Viken Hospital Trustlead
- University of Oslocollaborator
- Norwegian Directorate of Healthcollaborator
- Oslo University Hospitalcollaborator
- Norwegian Institute of Public Healthcollaborator
Study Sites (1)
Drammen Hospital
Drammen, Akershus, 3004, Norway
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
John munkhaugen, MD, PhD
Vestre Viken Trust, Drammen hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 7, 2021
First Posted
February 26, 2021
Study Start
February 25, 2021
Primary Completion
June 1, 2022
Study Completion
June 1, 2022
Last Updated
October 18, 2022
Record last verified: 2022-10